Dual role of tumor necrosis factor alpha in brain injury

Cytokine and Growth Factor Reviews

Volumn 10, Issue 2, 1999, Pages 119-130

  Shohami, Esther ^a   Ginis, Irene ^b   Hallenbeck, John M ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Cerebral ischemia; Traumatic brain injury; Tumor necrosis factor alpha

Indexed keywords

CARRIER PROTEIN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR BINDING PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL; BRAIN CELL; BRAIN INJURY; BRAIN ISCHEMIA; CELL DAMAGE; CELL REGENERATION; CYTOKINE PRODUCTION; GENETICS; HUMAN; METABOLISM; MOUSE; NONHUMAN; PHYSIOLOGY; REVIEW;

EID: 0032830106     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(99)00008-8     Document Type: Short Survey

References (102)

1. Waxweiler R.J., Thurman D., Sniezek J., Sosin D., O'Neil J. Monitoring the impact of traumatic brain injury: A review and update. Journal of Neurotrauma. 12:1995;509-516.
2. Gennarelli T.A.S. Animate models of human head injury. Journal of Neurotrauma. 11:1994;357-368.
3. Ommaya A.K. Head injury mechanisms and the concept of preventive management: A review and critical synthesis. Journal of Neurotrauma. 12:1995;527-546.
4. Povlishock J.T., Christman C.W. The pathobiology of traumatically induced axonal injury in animals and humans: a review of current thoughts. Journal of Neurotrauma. 12:1995;555-564.
5. McIntosh T.K., Smith D.H., Meaney D.F., Kotapka M.J., Gennarelli T.A., Graham D.I. Neuropathological sequelae of traumatic brain injury: Relationship to neurochemial and biomechanical mechanisms. Laboratory Investigation. 74:1966;315-342.
6. Rothwell N.J., Hopkins S.J. Cytokines and the nervous system II: action and mechanisms of action. Trends in Neuroscience. 18:1995;130-136.
7. Rothwell N.J., Strijbos P.J. Cytokines in neurodegeneration and repair. International Journal for Developmental Neuroscience. 13:1995;179-185.
8. Merril J.E., Benveniste E.N. Cytokines in inflammatory brain lesions: helpful and harmful. Trends in Neuroscience. 19:1996;331-338.
9. Barger S. Tumor Necrosis Factor, The good, the bad and the umbra. Mattson M.P. Neuroprotective Signal Transduction. 1998;163-183 Humana Press, Totowa, NJ.
10. Munoz-Fernandez M., Fresno M. The role of tumor necrosis factor, Interleukin-6, Interferon-γ and inducible nitric oxide synthase in the development and pathology of the nervous system. Progress in Neurobiology. 56:1998;307-340.
11. Tracey K.J., Cerami A. Tumor necrosis factor, other cytokines and disease. Annals Reviews of Cell Biology. 9:1993;317-342.
12. Perry V.H. A revised view of the central nervous system microenvironment and major histocompatability complex class II antigen presentation. Journal of Neuroimmunology. 90:1998;113-121.
13. Libby P., Sukhova G., Lee R.T., Galis Z.S. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. Journal of Cardiovascular Pharmacology. 25:(Suppl. 2):1995;S9-S12.
14. Vaddi K., Nicolini F.A., Mehta P., Mehta J.L. Increased secretion of tumor necrosis factor-α and interferon-γ by mononuclear leukocytes in patients with ischemic heart disease. Circulation. 90:1994;694-699.
15. Fagiolo U., Cossarizza A., Scala E., Emanuele F-B., Claudio O., Emanule C., Daniela M., Franceschi C., Paganelli R. Increased cytokine production in mononuclear cells of healthy elderly people. European Journal of Immunology. 23:1993;2375-2378.
16. Barath P., Fishbein M., Cao J., Berenson J., Helfant R.H., Forrester J.S. Detection and localization of tumor necrosis factor in human atheroma. The American Journal of Cardiology. 65:1990;297-302.
17. Tipping P.G., Hancock W.W. Production of tumor necrosis factor and interleukin-1 macrophages from human atheromatous plaques. American Journal of Pathology. 142:1993;1721-1728.
18. Grimaldi L.M., Martino G.V., Franciotta D.M., Brustia R., Castagna A., Pristera R., Prizzarin A. Elevated tumor necrosis factor-alpha levels on spinal fluid from HIV-1 infected patients with central nervous system inbodement. Annals of Neurology. 29:1991;21-25.
19. Leist T.P., Frei K., Kam-Hansen S., Zinkernagel R.M., Fontana A. Tumor necrosis factorα in cerebrospinal fluid during bacterial, but no viral, meningitis: evaluation in murine model infections and in patients. Journal of Experimental Medicine. 167:1988;1743-1758.
20. Tracey K.J., Lowry S.F. The role of cytokine mediators in septic shock. Advances in Surgery. 23:1990;21-56.
21. Tracey K.J. Tumor necrosis factor (cachectin) in the biology of septic shock syndrome. Circulatory Shock. 35:1991;123-128.
22. Jiang J., Tian K., Chen H., Zhu P., Wang Z. Kinetics of plasma cytokines and its clinical significance in patients with severe trauma. Chinese Medical Journal. 110:1997;923-926.
23. Morganti-Kossmann M.C., Kossmann T., Wahl S.M. Cytokines and neurophathology. Trends in Pharmacology Science. 13:1992;286-291.
24. Morganti-Kossmann M.C., Kossmann T. The immunology of brain injury. Immune responses in the central nervous system. 1995;159-187 Bio Scientific Publishers, Oxford.
25. Morganti-Kossman M.C., Lenzlinger P.M., Hans V., Stahel P., Csuka E., Ammann E., Stocker R., Trentz O., Kossmann T. Production cytokines following brain injury: beneficial and deleterious for the damaged tissue. Molecular Psychiatry. 2:1997;133-136.
26. Goodman J.C., Robertson C.S., Grossman R.G., Narayan R.K. Elevation of tumor necrosis factor in head injury. Journal of Neuroimmunology. 30:1990;213-217.
27. Ross S.A., Halliday M.I., Campbell G.C., Byrnes D.P., Rowlands B.J. The presence of tumor necrosis factor in CSF and plasma after severe head injury. British Journal of Neurosurgery. 8:1994;419-425.
28. Fassbender K., Rossol S., Kammer T., Daffertshofer M., Wirth S., Dollman M., Hennerici M. Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. Journal of Neurological Science. 122:1994;135-139.
29. Gourin C.G., Shackford S.R. Production of tumor necrosis factor-alpha and interleukin-1 beta by human cerebral microvascular endothelium after percussive trauma. Journal of Trauma. 42:1997;1101-1107.
30. Mathiesen T., Edner G., Ulfarsson E., Andersson B. Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-alpha following subarachnoid hemorrhage. Journal of Neurosurgery. 87:1997;215-220.
31. Kureshi S.A., Hofman F.M., Schneider J.H., Chin L.S., Apuzzo M.L., Hinton D.R. Cytokine expression in radiation-induced delayed cerebral injury. Neurosurgery. 35:1994;822-829.
32. Arvin B., Neville L.F., Barone F.C., Feuerstein G.Z. The role of inflammation and cytokines in brain injury. Neuroscience Biobehavior Review. 20:1996;445-450.
33. Hallenbeck J.M., Dutka A.J., Kochanek P.M., Siren A-L., Pezeskpour G.H., Feuerstein G.Z. Stroke-risk factors prepare rat brainstem tissues for a modified local Shwartzman Reaction. Stroke. 19:1988;863-869.
34. Siren A.L., Heldman E., Doron D., Lysko P.G., Yue T.L., Liu Y., Feuerstein G., Hallenbeck J.M. Release of proinflammatory and prothrombotic mediators in the brain and peripheral circulation in spontaneously hypertensive and normotensive Wistar-Kyoto rats. Stroke. 23:1992;1643-1650.
35. Siren A.L., Liu Y. Feuerstein G., Hallenbeck J.M. Increased release of tumor necrosis factor-alpha into the cerebrospinal fluid and peripheral circulation of aged rats. Stroke. 24:1993;880-886.
36. Siren A.L., McCarron R.M., Wang L., Garcia-Pinto P., Ruetzler C., Martin D., Felgenhauer K., Hallenbcek J.M. Monocyte activation and ischemic brain injury: Role of tumor necrosis factor-alpha and interleukin-1. Krieglstein J. Pharmacology of Cerebral Ischemia. 1996;429-435 Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart.
37. Siesjo B.K., Kristian T., Katsura K-I. Overview of bioenergetic failure and metabolic cascades in brain ischemia. Ginsberg M., Bogousslavsky J., Malden M.A. Cerebrovascular Disease: Pathophysiology, Diagnosis, and Management. 1998;3-13 Blackwell Science.
38. Siesjo B.K., Katsura K-I., Zhao Q., Folbergrova J., Pahlmark K., Siesjo P., Smith M-L. Mechanisms of secondary brain damage in global and focal ischemia: A speculative synthesis. Journal of Neurotrauma. 12:1995;943-956.
39. Rami A., Krieglstein J. Brain damage caused by ischemia: pathophysiological and pharmacological aspects. Dementia. 4:1993;21-31.
40. Feuerstein G.Z., Wang X., Barone F.C. Inflammatory gene expression in cerebral ischemia and trauma. Potential new therapeutic targets. Annals of New York Academy of Sciences. 825:1997;179-193. Review.
41. Liu T., Clark R.K., McDonnel P.C., Toung P.R., White R.F., Barone F.C., Feuerstein F.Z. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke. 25:1994;1481-1488.
42. Meirstrell M.E. III, Botchkina G.I., Wang H., Di Snato E., Cockroft K.M., Bloom O., Vishnubhakat J.M., Ghezzi P., Tracey K.J. Tumor necrosis factor is a brain damaging cytokine in cerebral ischemia. Shock. 8:1997;341-348.
43. Leker R., Shohami E., Abramsky O., Ovadia H., Dexanabinol; a novel neuroprotective drug in experimental focal cerebral ischemia, Journal of Neurological Science 1999;162:114-9.
44. Szaflarski J., Burtrum D., Silverstein F.S. Cerebral hypoxia-ischemia stimulates cytokine gene expression. Stroke. 26:1995;1093-1100.
45. Buttini M., Appel K., Sauter A., Gebicke-Haerter P.J., Boddeke H.W. Expression of tumor necrosis factor alpha after focal cerebral ischaemia in the rat. Neuroscience. 71:1996;1-16.
46. Saito K., Suyama K., Nishida K., Sei Y., Basile A.S. Early increases in TNF-alpha, IL-6 and IL-1 beta levels following transient cerebral ischemia in gerbil brain. Neuroscience Letters. 206:1996;149-152.
47. Barone F.C., Arvin B., White R.F., Miller A., Webb C.L., Willette R.N., Lysko P.G., Feuerstein G.Z. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke. 28:1997;1233-1244.
48. Woodroofe M.N., Sarna G.S., Wadhwa M., Hayes G.M., Loughlin A.J., Tinker A., Cuzner M.L. Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production. Journal of Neuroimmunology. 33:1991;227-236.
49. Rostworowski M., Balasingam V., Chabot S., Owens T., Yong V.W. Astrogliosis in the neonatal and adult murine brain post-trauma: elevation of inflammatory cytokines and the lack of requirement for endogenous interferon-gamma. Journal of Neuroscience. 17:1997;3664-3674.
50. Taupin V., Toulmond S., Serrano A., Benavides J., Zavala F. Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand. Journal of Neuroimmunology. 42:1993;177-185.
51. Shohami E., Gallily R., Mechoulam R., Bass R., Ben-Hur T. Cytokine production in the brain following closed head injury: Dexanabinol (HU-211) is a novel TNFα inhibitor and an effective neuroprotectant. Journal of Neuroimmunology. 72:1997;169-177.
52. Shohami E., Novikov M., Bass R., Yamin A., Gallily R. Closed head injury triggers early production of TNF and IL-6 by brain tissue. Journal of Cerebral Blood Flow & Metabolism. 14:1994;615-619.
53. Fan L., Young P.R., Barone F.C., Feuerstein G.Z., Smith D.H., McIntosh T.K. Experimental brain injury induces differential expression of tumor necrosis factor-α mRNA in the CNS. Molecular Brain Research. 36:1996;287-291.
54. Kita T., Liu L., Tanaka N., Kinoshita Y. The expression of tumor necrosis factor-alpha in the rat brain after fluid percussive injury. International Journal of Legal Medicine. 110:1997;305-311.
55. Holmin S., Schalling M., Hojeberg B., Sandberg Nordqvist A-C., Skeftruna A-K., Mathiesen T. Delayed cytokine expression in rat brain following experimental contusion. Journal of Neurosurgery. 86:1997;493-504.
56. De-Vries H.E., Blom-Roosemalen M.C., van-Oosten M., de Boer A.G., van Berkel T.J., Breimer D.D., Kuiper J. The influence of cytokines on the integrity of the blood brain-barrier in vitro. Journal of Neuroimmunology. 64:1996;37-43.
57. Pober J.S., Cotran R.S. Cytokines and endothelial cell biology. Physiological Reviews. 70:1990;427-451.
58. Rosenberg G.A., Estrada E.Y., Dencoff J.E., Stetler-Stevenson W.G. Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window. Brain Research. 703:1995;151-155.
59. Stahel P.F., Frei K., Eugster H.P., Fontana A., Hummel K.M., Wetsel R.A., Ames R.S., Barnum S.R. TNF-alpha-mediated expression of the receptor for anaphylatoxin C5a on neurons in experimental Listeria meningoencephalitis. Journal of Immunology. 159:1997;861-869.
60. Tchelingerian J.L., Monge M., Le Saux F., Zalc B., Jacque C. Differential oligodendroglial expression of the tumor necrosis factor receptors in vivo and in vitro. Journal of Neurochemistry. 65:1995;2377-2380.
61. Faber-Elman A., Lavie V., Schvartz I., Shaltiel S., Schwartz M. Vitronectin overrides anegative effect of TNF-α on astrocyte migration. Federation of American Society of Experimental Biology Journal. 9:1995;1605-1613.
62. Reid T.R., Torti F.M., Ringol G.M. Evidence for two mechanisms by which tumor necrosis factor kills cells. Journal of Biological Chemistry. 264:1991;4583-4589.
63. Yamasaki T., Kikuchi H., Moritake K., Nagao S., Iwasaki K., Paine J.T., Kagawa T., Namba Y. A morphological and ultrastructural investigation of normal mouse brain tissue after intracerebral injection of tumor necrosis factor. Journal of Neurosurgery. 77:1992;279-287.
64. Marriot J.B., Westby M., Dalgleish A.G. Therapeutical potential of TNF-α inhibitors old and new. Drug Discovery Today. 2:1997;273-282.
65. Buttini M., Mir A., Appel K., Wiederhold K.H., Limonta S., Gebicke-Haerter P.J., Boddeke H.W. Lipopolysaccharide induces expression of tumour necrosis factor alpha in rat brain: inhibition by methylprednisolone and by rolipram. British Journal of Pharmacology. 122:1997;1483-1489.
66. Weber C. Involvement of tyrosine phosphorylation in endothelial adhesion molecule induction. Immunological Research. 15:1996;30-37. Review.
67. Novogrodsky A., Vanichkin A., Patya M., Gazit A., Osherov N., Levitzki A. Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science. 264:1994;1319-1322.
68. Moreira A.L., Sampaio E.P., Zmuidzinas A., Frindt P., Smith K.A., Kaplan G. Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. Journal of Experimental Medicine. 177:1993;1675-1680.
69. Bianchi M., Bloom O., Raabe T., Cohen P.S., Chesney J., Sherry B., Schmidtmayerova H., Calandra T., Zhang X., Bukrinsky M., Ulrich P., Cerami A., Tracey K.J. Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone. Journal of Experimental Medicine. 183:1996;927-936.
70. Cohen P.M., Nakshatri H., Dennis J., Caragine T., Bianchi M., Cerami A., Tracey K.J. CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency. Proceedings of the National Academy of Sciences USA. 93:1996;3967-3971.
71. Shohami E., Bass R., Wallach D., Yamin A., Gallily R. Inhibition of tumor necrosis factor (TNFα) activity in rat brain is associated with cerebroprotection after closed head injury. Journal of Cerebral Blood Flow & Metabolism. 16:1996;378-384.
72. Shohami E., Novikov M., Bass R. Long term effect of HU-211, a novel noncompetitive NMDA antagonist, on motor and memory functions after closed head injury in the rat. Brain Research. 674:1995;55-62.
73. Shohami E., Weidenfeld J., Ovadia H., Vogel Z., Hanus L., Fride E., Breuer A., Ben-Shabat S., Sheskin Z., Mechoulam R. Endogenous and synthetic cannabinoids: Recent advances. CNS Drug Reviews. 2:1996;429-451.
74. Zhai Q.H., Futrell N., Chen F.J. Gene expression of IL-10 in relation to TNF-alpha, IL-1beta and IL-2 in the rat brain following middle cerebral artery occlusion. Journal of Neurological Science. 152:1997;119-124.
75. Knoblach S.M., Faden A.I. Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury. Experimental Neurology. 153:1998;143-151.
76. Lavine S.D., Hofman F.M., Zlokovic B.V. Circulating antibody against tumor necrosis factor alpha protects rat brain from reperfusion injury. Journal of Cerebral Blood Flow & Metabolism. 18:1998;52-58.
77. Yang G.Y., Gong C., Qin Z., Ye W., Mao Y., Bertz A.L. Inhibition of TNFalpha attenuates infarct volume and ICAM-1 expression in ischemic mouse brain. Neuroreport. 9:1998;2131-2134.
78. Peetre C., Thysell H., Grubb A., Olsson I. A tumor necrosis factor binding protein is present in human biological fluids. European Journal of Haematology. 41:1988;414-423.
79. Engelmann H., Aderka D., Rubinstein M., Rotman D., Wallach D. A tumor necrosis factor-binding protein purified to homogeneity from urine protects cells from tumor necrosis factor toxicity. Journal of Biological Chemistry. 264:1989;11974-11980.
80. Nophar Y., Kemper O., Brakebusch C., Engelmann H., Zwang R., Aderka D., Holtmann H., Wallach D. Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor. European Molecular Biology Organization Journal. 9:1990;3269-3278.
81. Dawson D., Martin D., Hallenbeck J.M. Inhibition of tumor necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rat. Neuroscience Letters. 218:1996;41-44.
82. Nawashiro H., Martin D., Hallenbeck J.M. Inhibition of tumor necrosis factor ameliorated brain infarction in mice. Journal of Cerebral Blood Flow & Metabolism. 17:1997;229-232.
83. Kitagawa K., Matsumoto M., Kuwabara K., Tagaya M., Ohtsuki T., Hata R., Ueda H., Handa N., Kimura K., Kamada T. 'Ischemic tolerance' phenomenon detected in various brain regions. Brain Research. 561:1991;203-211.
84. Kirino T., Tsujita Y., Tamura A. Induced tolerance to ischemia in gerbil hippocampal neurons. Journal of Cerebral Blood Flow & Metabolism. 11:1991;299-307.
85. Ohtsuki T., Ruetzler C.A., Tasaki K., Hallenbeck J.M. Interleukin-mediates induction of tolerance to global ischemia in gerbil hippocampal CA1 neurons. Journal of Cerebral Blood Flow and Metabolism. 16:1996;1137-1142.
86. Tasaki K., Ruetzler C.A., Ohtsuki T., Martin D., Nawashiro H., Hallenbeck J.M. Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Research. 748:1997;267-270.
87. Nawashiro H., Tasaki K., Ruetzler C.A., Hallenbeck J.M. TNF-α pretreatment induces protective effects against focal cerebral ischemia in mice. Journal of Cerebral Blood Flow and Metabolism. 17:1997;483-490.
88. Bruce A.J., Boling W., Kindy M.S., Peschon J., Kraemer P.J., Carpenter M.K., Holtsberg F.W., Mattson M.P. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nature Medicine. 2:1996;788-794.
89. Scherbel U., Raghupathi R., Nakamura M., Saatman K.E., McIntosh T.K. Evaluation of neurobehavioral deficits in brain injured tumor necrosis factor-deficient (TNF-/-) mice after experimental brain injury. Journal of Neurotrauma. 14:1997;781. (abs).
90. Gary D.S., Bruce-Keller A.J., Kindy M.S., Mattson M.P. Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. 1283. 18:1998;1287.
91. Shen Y., Li R., Shiosaki K. Inhibition of p75 tumor necrosis factor receptor by antisense oligonucleotides increases hypoxic injury and beta-amyloid toxicity in human neuronal cell line. Journal of Biological Chemistry. 272:1997;3550-3553.
92. Hsu H.L., Shu H.B., Pan M.G., Goeddel D.V. TRADD-TRAF2 and TRASS-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 84:1996;299-308.
93. Barger S.W., Horster D., Furukawa K., Goodman Y., Krieglstein J., Mattson M.P. Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proceedings of the National Academy of Sciences USA. 92:1995;9328-9332.
94. Mattson M.P., Cheng B., Baldwin S.A., Smith-Swintosky V.L., Keller J., Geddes J.W., Scheff S.W., Christakos S. Brain injury and tumor necrosis factors induce calbindin D-28k in astrocytes: evidence for a cytoprotective response. Journal of Neuroscience Research. 42:1995;357-370.
95. Wilde G.J., Pringle A.K., Sundstrom L.E., Iannotti F. Tumor necrosis factor attenuates hypoxic/hypoglycaemic damage in organotypic hippocampal cultures. Journal of Cerebral Blood Flow and Metabolism. 15:1995;S263.
96. Ginis I., Schweizer U., Brenner M., Liu J., Azzam N., Spatz M., Hallenbeck J.M., TNF-α pretreatment prevents subsequent activation of cultured brain cells with TNF-α and hypoxia via ceramide. American Journal of Physiology (Cell Physiol.) 1999; (in press).
97. Schmidt K.N., Amstad P., Cerutti P., Baeuerle P.A. The roles of hydrogen peroxide and superoas messangers in the activation of transcription factor NF-kappa B. Chemical Biology. 2:1995;13-22.
98. Beit-Yannai E., Kohen R., Horowitz M., Trembovler V., Shohami E. Changes in biological reducing activity in rat brain following closed head injury: a cyclicvoltammetry study in normal and acclimated rats. Journal of Cerebral Blood Flow & Metabolism. 17:1997;273-279.
99. Mattson M.P., Barger S.W., Furukawa K., Bruce A.J., Wyss-Coray T., Mark R.J., Mucke L. Cellular signaling role of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease. Brain Research Reviews. 23:1997;47-61.
100. Mattson M.P. Neuroprotective signal transduction: Relevance to stroke. Neuroscience and Biobehavioral Reviews. 21:1997;193-206.
101. O'Neill L.A.J., Kaltschmidt C. NF-kB: a crucial transcription factor for glial and neuronal cell function. Trends in Neuroscience. 20:1997;252-258.
102. Trembovier V, Beit-Yannai E, Younis F, Gallily R, Horowitz M, Shohami E. Antioxidants attenuate acute toxicity of tumor necrosis factor α induced by brain injury in rat. J Interferon and Cytokine Res 1999; (in press).